You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (105)

Journals (0)

1-10 of 105 results for Hormone receptor positive advanced breast cancer

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Treating Elderly Patients with Hormone Receptor–Positive Advanced Breast Cancer

Open access

Review article

First published 2015

Treating Elderly Patients with Hormone Receptor–Positive Advanced Breast Cancer

David Riseberg

Clinical Medicine Insights: Oncology

Select article: Overall survival and progression-free survival with endocrine therapy for hormone receptor-positive,HER2-negative advanced breast cancer: review

Open access

Review article

First published 2017-11

Overall survival and progression-free survival with endocrine therapy for hormone receptor-positive,HER2-negative advanced breast cancer: review

Tomás Reinert, Carlos H. Barrios

Therapeutic Advances in Medical Oncology

Select article: Recent advances in the treatment of hormone receptor-positive/human epidermal growth factor 2-positive advanced breast cancer

Open access

Review article

First published 2021

Recent advances in the treatment of hormone receptor-positive/human epidermal growth factor 2-positive advanced breast cancer

Huimin Lv, Min Yan, Zefei Jiang

Therapeutic Advances in Medical Oncology

Select article: The introduction of a third CDK4/6 inhibitor does not change the cost-effectiveness profile in first and subsequent-lines after progression or relapse during previous endocrine therapy in patients with hormone receptor positive (HR+)/human epidermal receptor-2 negative (HER-2) advanced or metastatic breast cancer

Retricted access

Article commentary

First published 2020-9

The introduction of a third CDK4/6 inhibitor does not change the cost-effectiveness profile in first and subsequent-lines after progression or relapse during previous endocrine therapy in patients with hormone receptor positive (HR+)/human epidermal receptor-2 negative (HER-2) advanced or metastatic breast cancer

Jacopo Giuliani, Andrea Bonetti

Journal of Oncology Pharmacy Practice

Select article: Review of Cyclin-Dependent Kinase 4/6 Inhibitors for the Treatment of Hormone Receptor–Positive Advanced Breast Cancer

Retricted access

Review article

First published 2019-2

Review of Cyclin-Dependent Kinase 4/6 Inhibitors for the Treatment of Hormone Receptor–Positive Advanced Breast Cancer

Keith A. Hecht, Christopher Selby

Annals of Pharmacotherapy

Select article: Delaying Chemotherapy in the Treatment of Hormone Receptor–Positive,Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer

Open access

Review article

First published 2015

Delaying Chemotherapy in the Treatment of Hormone Receptor–Positive,Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer

Adam M. Brufsky

Clinical Medicine Insights: Oncology

Select article: Time to treatment failure of palbociclib and letrozole as second-line therapy or beyond in hormone receptor-positive advanced breast cancer

Retricted access

Research article

First published 2019-9

Time to treatment failure of palbociclib and letrozole as second-line therapy or beyond in hormone receptor-positive advanced breast cancer

M Alexandra Schickli, Michael J Berger, Maryam Lustberg [...]

Journal of Oncology Pharmacy Practice

Select article: Effectiveness of combined targeted and hormonal therapies for post-menopausal women with hormone receptor-positive and HER2-negative advanced breast cancer: A systematic review and meta-analysis of RCTs

Retricted access

Research article

First published 2025-12

Effectiveness of combined targeted and hormonal therapies for post-menopausal women with hormone receptor-positive and HER2-negative advanced breast cancer: A systematic review and meta-analysis of RCTs

Vitalis Okwor, Chika Juliet Okwor, Maryjane Ukwuoma [...]

Journal of Oncology Pharmacy Practice

Select article: Role of Goserelin in Combination with Endocrine Therapy for the Treatment of Advanced Breast Cancer in Premenopausal Women Positive for Hormone Receptor: A Retrospective Matched Case–Control Study

Retricted access

Research article

First published 2013-12

Role of Goserelin in Combination with Endocrine Therapy for the Treatment of Advanced Breast Cancer in Premenopausal Women Positive for Hormone Receptor: A Retrospective Matched Case–Control Study

Sangang Wu, Qun Li, Yuliang Zhu [...]

Cancer Biotherapy and Radiopharmaceuticals

Select article: Everolimus treatment in patients with hormone receptor-positive and human epidermal growth factor receptor 2-negative advanced breast cancer and a predictive model for its efficacy: a multicenter real-world study

Open access

Research article

First published 2024

Everolimus treatment in patients with hormone receptor-positive and human epidermal growth factor receptor 2-negative advanced breast cancer and a predictive model for its efficacy: a multicenter real-world study

Yujing Tan, Zexi Peng, Hanfang Jiang [...]

Therapeutic Advances in Medical Oncology

1
2
3
•••
11
10 / page

Article type

Publication date

Subjects

Access